Patrick Archdeacon
Medical Officer
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Deborah Ascheim
Associate Professor, Clinical Director of Research, InCHOIR
Mount Sinai School of Medicine
Christopher Beardmore
Chief Executive Officer
Translational Research Management, LLC
Stefano Bertuzzi
Director, Office of Science Policy, Planning and Communications
National Institutes of Mental Health
Sue Bogner
Chief Scientist
Institute for the Study of Human Error, LLC
Pamela Bradley
Director, Science Policy
American Association for Cancer Research
Linda Brady
Director, Division of Neuroscience and Basic Behavioral Science
National Institute of Mental Health
P. J. Brooks
Health Science Administrator
Office of Rare Diseases Research
National Institutes of Health
Steven Brotman
Senior Vice President, Payment and Health Care Delivery Policy
AdvaMed
Suanna Bruinooge
Director, Research Policy
American Society of Clinical Oncology
Barbara Buch
U.S. Food and Drug Administration
Liza Bundesen
Acting Chief, Science Policy and Evaluation Branch
Office of Science Policy, Planning, and Communications
National Institute of Mental Health
Robert Califf
Director, Duke Translational Medicine Institute
Vice Chancellor for Clinical and Translational Research
Professor of Medicine
Duke University Medical Center
Scott Campbell
Executive Director & CEO
Foundation for the National Institutes of Health
Tanisha Carino
Senior Vice President
Avalere Health
Kelli Carrington
Lead, Public Affairs
National Institutes of Health Clinical Center
Christine Carter
Vice President, Scientific Affairs
Society for Women’s Health Research
Dorothy Castille
National Institute on Minority Health and Health Disparities
National Institutes of Health
Carroll Child
Clinical Research Risk Manager
University of California, San Francisco
Charles Clayton
Director of Training
American Society of Hematology
Elaine Collier
Senior Advisor to Director
National Center for Research Resources
National Institutes of Health
Doug Cropper
President and Chief Executive Officer
Genesis Health System
Dennis Cryer
Chief Medical Officer CryerHealth
Donna Cryer
CEO
Cryer Health
Ulyana Desiderio
Senior Manager for Scientific Affairs
American Society of Hematology
Dinora Dominguez
Chief, Patient Recruitment and Public Liasion
National Institutes of Health Clinical Center
James Doroshow
Director, Division of Cancer Treatment and Diagnosis
National Cancer Institute
National Institutes of Health
Jeffrey Drazen
Editor-in-Chief
New England Journal of Medicine
Peggy Eastman
Oncology Times
Paul Eisenberg
Senior Vice President, Global Regulatory Affairs and Safety
Amgen Inc.
Lynn Etheredge
Consultant, Rapid Learning Project
George Washington University
Gary Filerman
President
Atlas Health Foundation
Louis Fiore
Principal Investigator, VA Cooperative Studies Program
Director, VA Cooperative Studies Program Coordinating Center, Boston
Department of Veterans Affairs
J. Michael Fitzmaurice
Senior Science Advisor for Information Technology
Agency for Healthcare Research and Quality
Mark Fleury
Associate Director, Science Policy
American Association for Cancer Research
Sherine Gabriel
William J. and Charles H. Mayo Professor of Medicine & Epidemiology, Mayo Medical School
Co-Principal Investigator and Director of Education, Mayo Clinical Center for Translational Scientific Activities (CTSA)
Jenny Gaffney
Senior Manager
Avalere Health
Elaine Gallin
Principal
QE Philanthropic Advisors
John Gallin
Director, Clinical Center
National Institutes of Health
Annetine Gelijns
Professor of Health Policy
Co-Chair, Department of Health Evidence and Policy
Mount Sinai School of Medicine
Robert Giffin
Vice President, Healthcare Policy and Reimbursement
Covidien
Andrea Giuffrida
Health Scientist—AAAS Science & Technology Policy Fellow
Office of Science Policy
National Institutes of Health
Rashmi Gopal-Srivastava
Director, Extramural Research Program
Office of Rare Diseases Research
National Institutes of Health
Jennifer Graff
Research Director, Methods, Evidence & Coverage
National Pharmaceutical Council
Cheryl Grandinetti
Health Scientist Policy Analyst
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Candice Griffin
Senior Program Manager
American Society of Clinical Oncology
Claudia Grossmann
Program Officer
Institute of Medicine
Kristi Guillory
Senior Policy Analyst
American Cancer Society
Felix Gyi
CEO
Chesapeake IRB
Anthony Hayward
Director, Division for Clinical Research Resources
National Center for Research Resources
National Institutes of Health
Elina Hemminki
Professor
National Institute for Health and Welfare, Helsinki, Finland
Janie Hofacker
Director of Programs
Association of American Cancer Institutes
Jeffrey Humphrey
Executive Director
Bristol-Myers Squibb
Ekopimo Ibia
Director
Merck & Co., Inc.
John Iglehart
National Correspondent
New England Journal of Medicine
Rebecca Jackson
Professor and Associate Dean for Clinical Research
Director and Principal Investigator, OSU Center for Clinical and Translational Science
The Ohio State University
Michael King Jolly
Senior Vice President
Quintiles Innovation
Rasika Kalamegham
Senior Associate
Pew Charitable Trusts
Petra Kaufmann
Director, Office of Clinical Research
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Dominick Kennerson
Director
CryerHealth
Steven King
Assistant Executive Director
American College of Radiology
Timothy King
Director
PRA International
Roger Klein
Medical Director, Molecular Oncology
Blood Center of Wisconsin, Medical College of Wisconsin
Charles Knirsch
Vice President, Clinical Research
Pfizer Inc.
Hon-Sum Ko
Medical Officer
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Kathy Kopnisky
Senior Policy Analyst, Advisor for Regulatory Science
Office of Science Policy
National Institutes of Health
Ronald Krall
Associate Fellow
Center for Bioethics
University of Pennsylvania
Judith Kramer
Associate Professor of Medicine, Duke University Medical Center
Executive Director, Clinical Trials Transformation Initiative (CTTI)
Steven Krosnick
Program Director
National Cancer Institute
National Institutes of Health
Kelly Lai
Director of Science and Regulatory Affairs
Biotechnology Industry Organization
Michael Lauer
Director, Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute
National Institutes of Health
David Leventhal
Director, Clinical Innovation
Pfizer Inc.
Shao-Lee Lin
Executive Medical Director
Amgen Inc.
Bryan Luce
Senior Vice President, Science Policy
United BioSource Corporation
Kelsey Mace
Program Coordinator
American Society of Clinical Oncology
Diane Maloney
Associate Director for Policy
Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
Michael Marcarelli
Director, Division of Bioresearch Monotoring
Office of Compliance, Center for Devices and Radiological Health
U.S. Food and Drug Administration
Karen Margolis
Professor of Medicine, University of Minnesota Medical School
Director of Clinical Research
HealthPartners Research Foundation
Paula McKeever
Senior Policy Coordinator
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Marissa Miller
Chief, Advanced Technologies and Surgery Branch
National Heart, Lung, and Blood Institute
National Institutes of Health
Carol Mimura
Assistant Vice Chancellor for Intellectual Property & Industry Research Alliances (IPIRA)
University of California, Berkeley
Briggs Morrison
Senior Vice President
Worldwide Medical Excellence
Pfizer Inc.
Catherine Muha
Public Health Advisor National Cancer Institute
National Institutes of Health
Sharon Murphy
Scholar-in-Residence
National Cancer Policy Forum
Institute of Medicine
Richard Murray
Vice President, Global Center for Scientific Affairs
Office of the Chief Medical Officer
Merck & Co., Inc.
Elizabeth Ness
Nurse Consultant
National Cancer Institute
National Institutes of Health
Martha Nolan
Vice President, Public Policy
Society for Women’s Health Research
Ann O’Mara
Program Director
National Cancer Institute
National Institutes of Health
Keiko Ono
Senior Program Associate
National Research Council
John Orloff
Chief Medical Officer and Senior Vice President, Global Development, US Medical & Drug Regulatory Affairs
Novartis Pharmaceuticals Corporation
Maggie Owner
Government Affiars Consultant
Lewis-Burke Associates LLC
Rose Mary Padberg
Public Health Advisor
National Cancer Institute
National Institutes of Health
Linda Parreco
Public Health Advisor
National Cancer Institute
National Institutes of Health
Gary Persinger
Consultant
National Pharmaceutical Council
Richard Platt
Professor, Harvard Medical School
Co-Chair, Clinical Effectiveness Research Innovation Collaboration
IOM Roundtable on Value and Science-Driven Health Care
Laura Povlich
AAAS Congressional Fellow
Representative Sandy Levin
Mary Purucker
National Center for Research Resources
National Institutes of Health
Elizabeth Rach
Scientist
Cato Research Ltd.
Ihor Rak
Vice President, Clinical Neuroscience
AstraZeneca
Domenic Reda
Director
VA Cooperative Studies Program Coordinating Center
Stephanie Reffey
Research Science Manager
Susan G. Komen for the Cure
Theodore Reiss
Research Professor of Medicine
Vanderbilt
John Reppas
Director of Public Policy
Neurotechnology Industry Organization
Gloria Romanelli
Senior Director
American College of Radiology
Patrick Rooney
Co-Founder
Bionymity, Inc.
Jean Rouleau
Scientific Director, Institute of Circulatory and Respiratory Health
Canadian Institutes of Health Research
Arthur Rubenstein
Professor, Department of Medicine, Division of Endocrinology
Raymond and Ruth Perelman School of Medicine
University of Pennsylvania
Emily Rubinstein
Manager, Data Analytics
Context Matters
Richard Rudick
Hazel Prior Hostetler Chair of Neurology, Cleveland Clinic
Professor of Medicine, Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Deborah Runkle
Senior Program Associate
American Association for the Advancement of Science
Jody Sachs
Program Officer
National Center for Research Resources
National Institutes of Health
Chas Scammell
Director, New York Pharmaceutical Practice
Milliman
Amber Hartman Scholz
Assistant Executive Director
President’s Council of Advisors on Science and Technology & Office of Science and Technology Policy
Jeff Schomisch
Senior Managing Editor
Guide to Good Clinical Practice
Kevin Schulman
Professor of Medicine and Gregory Mario and Jeremy Mario Professor of Business Administration
Duke University School of Medicine and the Fuqua School of Business
Talisha Searcy
Program Analyst
Office of Inspector General, Office of Evaluation and Inspections
U.S. Department of Health and Human Services
Joe Selby
Executive Director
Patient-Centered Outcomes Research Institute
Lisa Shapiro
Associate Director, Clinical Program Management
Astellas Pharma Global Development
Rachel Sherman
Associate Director for Medical Policy
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Mark Smith
Policy Counsel
National Coalition for Cancer Research
Phillip Smith
Director, Planning, Evaluation and Research
Indian Health Service
Heather Snyder
Senior Associate Director, Scientific Grants
Alzheimer’s Association
Anil Srivastava
Director
Open Health Systems Laboratory
Scott Steele
Director, Research Alliances
University of Rochester
Kathleen Stratton
Project Director
Pew Charitable Trusts
Tibor Szentendrei
Senior Clinical Research Scientist
KAI Research, Inc.
Carmen Tamayo
R&D Consultant
HeteroGeneity, LLC
Jacob Tenai
Director
Orphan Child Africa Organization
Umesh Thakkar
Senior General Engineer
U.S. Government Accountability Office
Douglas Throckmorton
Deputy Director, Center for Drug Evaluation & Research
U.S. Food and Drug Administration
Janet Tobias
President Sierra/Tango Productions
Ikana Media
Sean Tunis
President & CEO
Center for Medical Technology Policy
Kathleen Uhl
Deputy Director, Office of Medical Policy
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Jill Wechsler
Washington Editor
Pharmaceutical Executive magazine
Neil Weisfeld
New Associates, LLC
Neil Weissman
President
MedStar Health Research Institute
Clarissa Wittenberg
Consultant
European Organization for Research and Treatment of Cancer
Hui-Hsing Wong
Medical Officer
Assistant Secretary for Planning and Evaluation
U.S. Department of Health and Human Services
Alastair Wood
Partner & Managing Director
Symphony Capital LLC
Janet Woodcock
Director
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Clyde Yancy
Magerstadt Professor of Medicine, Chief, Division of Cardiology
Feinberg School of Medicine, Northwestern University
Tara Yazinski
Advocate
National Fibromyalgia and Chronic Pain Association
John Yeh
Professor
Massachusetts General Hospital, Harvard
Peter Yu
Oncologist, Palo Alto Medical Foundation
Chair, Electronic Health Record Working Group
American Society of Clinical Oncology
Deborah Zarin
Director, ClinicalTrials.gov
National Library of Medicine
Paul Zimmet
Research Advocate
Parkinson’s Disease Foundation
Bram Zuckerman
Director
Division of Cardiovascular Devices
U.S. Food and Drug Administration